Cancer immunotherapy drugs known as immune checkpoint inhibitors (ICIs) can be miracle drugs for cancer patients, curing some and turning deadly disease into a manageable chronic condition in others.
Professor Jinyang Liang, specializing in ultrafast imaging and biophotonics at INRS, has developed with colleagues at INRS and Université de Montréal a minimally invasive technology to detect skin ...
For Rita Wilson, body positivity isn't all sunshine and rainbows. The actress and country music singer, who was diagnosed with breast cancer in 2015, opened up about how the health battle impacted her ...
Proton exchange membrane fuel cells (PEMFCs) are promising for zero-emission vehicles, but their sub-zero start-up capability remains a major hurdle. Freezing of product water inside the membrane ...
A new artificial intelligence tool called Sybil is helping doctors predict lung cancer risk years before it appears on scans, potentially closing gaps in current screening guidelines. Standard lung ...
Sarasota Memorial Health Care System recently reported that 75% of lung cancers diagnosed through an innovative early detection program at SMH’s Brian D. Jellison Cancer Institute in 2025 were found ...
If you could know your risk for developing cancer, would you want to? Increasingly, people are saying yes. Personalized cancer screening and detection tests have surged in recent years, and accessing ...
ROCHESTER, Minn. — Minnesota's world-renowned Mayo Clinic continues to live up to its reputation for achieving medical miracles, announcing Wednesday it has developed a test to detect pancreatic ...
A new light-based sensor can spot incredibly tiny amounts of cancer biomarkers in blood, raising the possibility of earlier and simpler cancer detection. The technology merges DNA nanotechnology, ...
Cancer claims more than 10 million lives every year globally. Research shows that detecting cancer early can greatly improve a patient’s chance of survival. And yet we lack reliable, affordable tools ...
Biomarkers play a pivotal role in contemporary cancer immunotherapy by guiding diagnosis, patient stratification, therapeutic decision-making, and longitudinal assessment of treatment responses.